Search tool

Summary: Substance use is generally associated with young people, but such problems have no age limits. Current evidence in relation to the elderly is limited, making it difficult to estimate the precise...

Concerns are increasing in the EU about the use of chemicals employed in the manufacture of the recreational drug GHB. The report GHB and its precursor GBL: an emerging trend case study...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...

This bookmark promotes the EMCDDA publications database, which contains a full collection of EMCDDA titles. Here users can search publications by: title; year; series or type; target group and keywords. Products are...

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

Monitoring the incidence of problem drug use — the rate at which people who will become problem users start using or injecting drugs for the first time — plays an important part...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...